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Background: A double-network (DN) gel, which is composed of poly(2-acrylamido-2-methylpropanesulfonic acid)
and poly(N,N’-dimethyl acrylamide), can induce hyaline cartilage regeneration in vivo in a large osteochondral
defect. The purpose of this study was to clarify the influence of the thickness of the implanted DN gel on the
induction ability of hyaline cartilage regeneration.
Methods: Thirty-eight mature rabbits were used in this study. We created an osteochondral defect having a
diameter of 4.3-mm in the patellofemoral joint. The knees were randomly divided into 4 groups (Group I: 0.5-mm
thick gel, Group II: 1.0-mm thick gel, Group III: 5.0-mm thick gel, and Group IV: untreated control). Animals in each
group were further divided into 3 sub-groups depending on the gel implant position (2.0-, 3.0-, or 4.0-mm depth
from the articular surface) in the defect. The regenerated tissues were evaluated with the Wayne’s gross and
histological grading scales and real time PCR analysis of the cartilage marker genes at 4 weeks.
Results: According to the total Wayne’s score, when the depth of the final vacant space was set at 2.0 mm, the
scores in Groups I, II, and III were significantly greater than that Group IV (p < 0.05), although there were no
significant differences between Groups I and IV at a 3.0-mm deep vacant space. The expression levels of type-2
collagen in Groups II and III were significantly higher (p < 0.05) than that in Group IV.
Conclusions: The 1.0-mm thick DN gel sheet had the same ability to induce hyaline cartilage regeneration as the
5.0-mm thick DN gel plug. However, the induction ability of the 0.5-mm thick sheet was significantly lower when
compared with the 1.0-mm thick gel sheet. The 1.0-mm DN gel sheet is a promising device to establish a cell-free
cartilage regeneration strategy that minimizes bone loss from the gel implantation.
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Cartilage defects are common in symptomatic knees and
an increasing health care concern. It has been a common
belief that the articular hyaline cartilage tissue cannot
spontaneously regenerate in vivo [1,2]. Therefore, the most
prevalent strategy to repair the osteochondral defect is to
fill the defect with a tissue-engineered cartilage-like tissue* Correspondence: nobukita@aol.com
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reproduction in any medium, provided the oror a cell-seeded scaffold material [3-10]. Recently, some
investigators have tried to fill an osteochondral defect with
acellular polymer scaffolds to induce cartilage cell regener-
ation [11-14]. However, it could not be applied for clinical
use due to various hurdles. Thus, functional repair of ar-
ticular cartilage defects remains a major challenge in tissue
regeneration medicine.
Recently, we have found that, when we implant a 5 to
8-mm thick PAMPS/PDMAAm double-network (DN) gel
plug at the bottom of a large osteochondral defect created
in the rabbit knee joint so that a 2- to 3-mm deep vacantl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ation can be induced in vivo within only 4 weeks in the
vacant space [15]. This DN gel is composed of poly
(2-acrylamido-2-methylpropanesulfonic acid) (PAMPS)
and poly (N,N´-dimethyl acrylamide) (PDMAAm). This
discovery has proposed a novel strategy to repair an
osteochondral defect in the field of joint surgery using
the artificially synthesized hydrogel without any cultured
cells or mammalian-derived scaffolds. We, therefore,
have confirmed the efficacy of this therapeutic strategy
with the 5-mm thick DN gel plug not only in the patel-
lofemoral joint but also in the femorotibial joint [16,17].
However, this therapeutic strategy with use of the 5-mm
thick DN gel plug has some drawbacks from the clinical
viewpoint: Namely, to implant the 5-mm thick DN gel
plug, we have to make a 7- to 8-mm deep bone defect
by surgically scraping the bottom of the defect. After
the cartilage regeneration will be achieved, the DN gel
plug will remain unabsorbed in the bone. Such intra-
osseous existence of the 5-mm thick DN gel plug may
not be adverse; however, it may become a future problem
in the case of revision surgery due to various reasons such
as infection, accidental trauma, and knee arthroplasty. The
thinner DN gel implant is better from the clinical view-
point in order to reduce the bone loss caused by the DN
gel implantation. However, there is a possibility that a thin
DN gel sheet may not have the same ability as the 5-mm
thick gel plug concerning induction of the in vivo cartilage
regeneration, because it may affect biomechanical environ-
ment in the defect. Thus, we have conducted this in vivo
study in order to clarify if the gel thickness influences on
the in vivo hyaline cartilage regeneration induced by the
DN gel implanted at the bottom of a large osteochondral
defect.
Recently, we have developed a DN gel sheet thinner than
1.0 mm with our advanced gel technology. In this study, we
have hypothesized that a 1-mm thin PAMPS/PDMAAm
DN gel sheet may be able to induce cartilage regeneration
in an osteochondral defect, when it was implanted at
the bottom of the defect so that a 2- to 3-mm deep va-
cant space was left in the defect, but that a 0.5-mm thin
DN gel sheet may not be able to induce cartilage regen-




The PAMPS/PDMAAm DN gel is a kind of interpene-
trating network hydrogel, but with an asymmetric struc-
ture: In the DN gel, the two independently cross-linked
polymer networks are physically entangled with each
other. This DN gel is strong enough (the compressive
fracture strength of 3.1 MPa [18]) to create an implant
plug, although the single network PAMPS and PDMAAmgels are too fragile as an implant in our pilot study.
The elastic modulus of the PAMPS/PDMAAm DN gel
is 0.20 MPa [18].
The PAMPS/PDMAAm DN gel was synthesized using
the previously reported two-step sequential polymerization
method [19]. Briefly, PAMPS hydrogel was obtained by
radical polymerization using N,N’-methylenebisacrylamide
(MBAA) as a cross-linker and 2-oxoglutaric acid as an
initiator. The monomer concentration was 1 mol/l for
PAMPS, 4 mol% for the cross-linker, and 0.1 mol% for
the initiator. Aqueous solution containing a monomer,
cross-linker, and the initiator was bubbled with nitrogen
for 30 minutes, and then injected into a cell consisting
of a pair of glass plates separated by a silicone rubber.
The cell was irradiated with a UV lamp (wave length
365 nm) for about 6 hours. The DN gel was synthesized
by the sequential network formation technique (two-
step method). The PAMPS hydrogel (1st network) was
immersed in an aqueous solution of 2 mol/L DMAAm,
containing 0.1 mol% MBAA, and 0.1 mol% 2-oxoglutaric
acid for one day until reaching the equilibrium. The 2nd
network (PDMAAm) was subsequently polymerized in the
presence of the PAMPS hydrogel by irradiating UV for
6 hours between two plates of glasses. After polymerization,
the PAMPS/PDMAAm DN gel was immersed in pure
water for 1 week and the water was changed twice daily
to remove any un-reacted materials. Using this principle
method, we created 5.0-mm thick DN gel blocks and
1.0- and 0.5-mm thick DN gel sheets, and then, 4.5-mm
diameter plugs or sheets were punched out from each
block or sheet. Subsequently, we prepared 5.0-mm thick
DN gel plugs as well as 1.0- and 0.5-mm thick DN gel
sheets, all of which had a 4.5-mm diameter.
Study design and animal experimentation
A total of 38 mature female Japanese white rabbits, 6 months
old and weighing 3.6 ± 0.7 kg, were used in this study.
Animal experiments were carried out in the Institute of
Animal Experimentation, Hokkaido University School of
Medicine under the Rules and Regulation of the Animal
Care and Use Committee, Hokkaido University School of
Medicine (Reference number: 08-0068).
In the first experiment, we used 30 rabbits. The bilateral
60 knees of the 30 rabbits were randomly divided into 4
groups of 15 knees each (Figure 1). An operation for each
animal was performed under intravenous anesthesia (pento-
barbital, 25 mg/kg) and sterile conditions. In each knee,
we created an osteochondral defect having a diameter of
4.3-mm in the femoral groove of the patellofemoral joint
using the previously reported procedure [15,16]. In Group
I, we implanted a 0.5-mm thick DN gel sheet at the bottom
of the osteochondral defect. In Group II, we implanted a
1.0-mm thick DN gel sheet at the bottom of the osteo-
chondral defect. In Group III, we implanted a 5.0-mm
Figure 1 Study design flowchart. In the first study, sixty knees of the 30 rabbits were randomly divided into 4 groups of 15 knees each in order
to clarify the effect of gel implant position (depth from the articular surface) in the defect on quality of the regenerated cartilage. The second
study was conducted using 8 rabbits to evaluate gene expression of type-2 collagen, aggrecan, and Sox9 in the tissue regenerated in the defect
using real-time PCR analysis.
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previous study. In Group IV, a defect was left vacant
without any implantation (Figure 2). In each group, the
15 knees were divided into 3 subgroups of 5 knees each.
In each subgroup, the defect was created so that the
depth of the final vacant space in the defect with or with-
out DN gel implantation became 2.0, 3.0, or 4.0 mm,
because our previous study showed that the regeneration
effect of DN gel implantation was observed in this range
of the vacant space depth [15]. For example, when the
depth of the final vacant space was set at 2.0 mm in each
Group, a defect was created with a depth of 2.5 mm in
Group I, 3.0 mm in Group II, 7.0 mm in Group III, and
2.0 mm in Group IV using drill, and then the DN gel sheet
or plug was implanted into the defect so that a vacant
space having a 2-mm depth from the articular cartilage
surface remained after surgery. Then, the incised joint cap-
sule and the skin wound were closed in layers with 3–0
nylon sutures, and an antiseptic spray dressing was applied.Postoperatively, each animal was allowed unrestricted
activity in a cage (310 x 550 x 320 mm) without any joint
immobilization. All rabbits were sacrificed at 4 weeks and
used for histological and immunohistochemical evaluations
after gross observations.
The second experiment was conducted using the re-
maining 8 rabbits, based on the first study results. The 16
knees in 8 rabbits were randomly divided into 4 groups
same manner as made in the first experiment and the final
vacant space was set at 2.0-mm depth. All rabbits were
sacrificed at 4 weeks, and real time polymerase chain reac-
tion (PCR) analysis was performed (Figure 1).
Examination methods
Gross observation for in vivo regenerated tissues
Immediately after sacrifice, the tissue regenerated in the
osteochondral defect was quantitatively evaluated with
the grading scale reported by Wayne et al. [14] Gross
appearance of each defect on the femoral condyle was
Figure 2 A schematic example of implantation of DN gel plugs and sheets. A; a 0.5-mm gel sheet was implanted at the bottom of the
defect. B; a 1.0-mm gel sheet was implanted at the bottom of the defect. C; a 5.0-mm gel plug was implanted at the bottom of the defect.
D; the control group has a defect left untreated. In each subgroup, the depth of the final vacant space in the defect with or without DN gel
implantation became 2.0, 3.0, or 4.0 mm. For example, when the depth of the final vacant space was set at 2.0 mm in each Group, a defect was
created with a depth of 2.5 mm in Group I, 3.0 mm in Group II, 7.0 mm in Group III, and 2.0 mm in Group IV using drill, and then the DN gel sheet or
plug was implanted into the defect so that a vacant space having a 2-mm depth from the articular cartilage surface remained after surgery. Note that
a vacant space (*) having the same depth from the articular cartilage surface remained after surgery in the same sub-group.
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defect margins (4 points), and surface (4 points). Thus,
the maximum total score was 16 points.Histological and immunohistochemical examinations
A distal portion of the resected femur was fixed in a
10% neutral buffered formalin solution for 3 days, decal-
cified with 50 mM EDTA for a period of 3–4 weeks, and
then cast in a paraffin block. The femur was sectioned
perpendicular to the longitudinal axis, and stained with
hematoxylin-eosin and Safranin-O. For immunohistochem-
ical evaluations, monoclonal antibody (anti-hCL (II), puri-
fied IgG, Fuji Chemical Industries Ltd, Toyama, Japan)
was used as primary antibodies. Immunostaining was
carried out according to the manufacturer’s instructions
using the Envision immunostaining system (DAKO Japan,
Kyoto, Japan). Finally, the sections were counterstained
with hematoxylin. Histology was evaluated with the scor-
ing system reported by Wayne et al. [14], which was com-
posed of matrix points (4 points), cell distribution points
(3 points), smoothness points of the surface (4 points),
Safranin O stain points (4 points), Safranin O-stained
area points (4 points). Thus, the maximum total score
was 19 points.Real time PCR analysis
Total RNA was extracted from the tissues regenerated in
the defect, using the RNeasy mini kit (Qiagen Inc., Valencia,
CA). RNA quality from each sample was assured by the
A260/280 absorbance ratio. The RNA (100 ng) was reverse-
transcribed into single strand cDNA using PrimeScriptW
RT reagent Kit (TakaraBio, Ohtsu, Japan). The RT reaction
was carried out for 15 minutes at 37 degrees Celsius and
then for 5 seconds at 85 degrees Celsius. All oligonucleotide
primer sets were designed based upon the published
mRNA sequence. The expected amplicon lengths ranged
from 93 to 189 bp. The sequences of primers used in real
time PCR analyses for rabbit regenerative tissues were as
follows: type-2 collagen forward GACCATCAATGGCGGC
TTC; reverse CACGCTGTTCTTGCAGTGGTAG. Aggre-
can forward GCTACGACGCCATCTGCTAC; reverse GTC
TGGACCGTGATGTCCTC. Sox9 forward AACGCCGAG
CTCAGCAAGA; reverse TGGTACTTGTAGTCCGGGT
GGTC. GAPDH forward CCCTCAATGACCACTTTGT
GAA; reverse AGGCCATGTGGACCATGAG. The real
time PCR was performed in Thermal Cycler DiceW TP800
(TakaraBio, Ohtsu, Japan) by using SYBRW Premix Ex
TaqTM (TakaraBio, Ohtsu, Japan). cDNA template (5 ng)
was used for real time PCR in a final volume of 25
microliter. cDNA was amplified according to the following
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Celsius for 30 sec at 40 amplification cycles. Fluorescence
changes were monitored with SYBR Green after every cycle.
A dissociation curve analysis was performed (0.5 degrees
Celsius /sec increase from 60 to 95 degrees Celsius with
continuous fluorescence readings) at the end of cycles
to ensure that single PCR products were obtained. The
amplicon size and reaction specificity were confirmed
by 2.5% agarose gel electrophoresis. The results were evalu-
ated using the Thermal Cycler DiceW Real Time System soft-
ware program (TakaraBio, Ohtsu, Japan). Glyceroaldehyde-
3-phosphate dehydrogenase (GAPDH) primers were used
to normalize samples.Statistical analysis
All data were described as the mean and standard devi-
ation values. A commercially available software program
(StatView 5.0, SAS Institute Inc., Cary, NC, USA) was used
for statistical calculation. The mean value of the Wayne’s
scores was statistically compared among groups using two-
way analysis of variance (ANOVA). Regarding the gene
expression of cartilage markers, one-way ANOVA was
performed for each gene. The Fisher’s protected least
significance difference test was used for post hoc multiple
comparisons. The significance level was set at p = 0.05.Figure 3 Gross observations of the joint surface repair at 4 weeks. Th
with a white opaque tissue. The defect having 3.0-mm depth in G- II and I
G-I was filled with inhomogenous white and reddish tissue. The defect in G
G-I; a 0.5-mm gel sheet was implanted at the bottom of the defect. G-II; a
5.0-mm gel plug was implanted at the bottom of the defect. G-IV; the conResults
Gross observation of the joint surface repair
In gross observation of the joint surface repair, the defect
having 2.0-mm depth with the 0.5-mm (Group-I), 1.0-mm
(Group-II), or 5.0-mm (Group-III) thick DN gel implant-
ation was completely filled with a white opaque tissue, while
the untreated defect (Group-IV: control) surface showed
reddish opaque, patchy tissues (Figure 3). The defect having
3.0-mm depth in Group-II, or -III was completely filled
with a white opaque tissue, while the Group-I and Group-
IV surface showed white and reddish opaque, patchy
tissues (Figure 3).Histological and immunohistochemical evaluations
In histological observations (Figure 4), the vacant space
remained after DN gel implantation was completely filled
with cartilaginous, fibrous, and/or bone tissues at 4 weeks.
It is noted that the void space inside the bone indicated
the presence of the DN gel, which was removed at prepar-
ation of the histological section. When the depth of the
final vacant space was set at 2.0 mm, the defect was com-
pletely filled with the proteoglycan-rich tissue positive for
Safranin-O staining with regenerated subchondral bone
tissue in Groups I, II, and III. When the depth of the
final vacant space was set at 3.0 mm, the defect wase defect having 2.0-mm depth in G-I, II, and III was completely filled
II was completely filled with a white opaque tissue, while the defect in
-IV showed reddish opaque, patchy tissues, independent of the depth.
1.0-mm gel sheet was implanted at the bottom of the defect. G-III; a
trol group has a defect left untreated.
Figure 4 Safranin-O and anti-type-2 collagen immunohistochemical staining at 4 weeks (2x original magnification). The defect in G-I, II,
and III was filled with a sufficient volume of the proteoglycan-rich tissue with regenerated subchondral bone tissue when the final vacant space
was set at 2.0 mm. The DN gel implantation in G-II and III also induced a sufficient volume of the proteoglycan-rich tissue in the defect having
3.0-mm depth. Immunohistochemical staining for type-2 collagen were consistent with Safranin-O staining. G-I; a 0.5-mm gel sheet was
implanted at the bottom of the defect. G-II; a 1.0-mm gel sheet was implanted at the bottom of the defect. G-III; a 5.0-mm gel plug was
implanted at the bottom of the defect. G-IV; the control group has a defect left untreated. Black scale bars show a length of 1 mm.
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for Safranin-O staining with regenerated subchondral bone
tissue in Group II and III, whereas there was little staining
with Safranin-O in Group I. In the Safranin-O stained area,
fairly large round cells rich in cytoplasm were scattered
singly or as an isogenous group. Some specimens with hya-
line cartilage regeneration appeared to be devoid of cells in
the superficial layer; thereby, resembling the lamina splen-
dens. On the other hand, the defect in Group IV was filled
with the fibrous and bone tissues, independent of the
depth. The edge of the adjacent cartilage showed slight
reduction of Safranin-O staining without the change in
cellularity. Immunohistochemical staining showed that
type-2 collagen was richly expressed in the same area
stained with Safranin-O (Figure 4).
Quantitative evaluations of gross appearance and
histology
Concerning the gross appearance score, the ANOVA
demonstrated that there was a significant difference not
only on the effect of the group (p < 0.0001) but also on the
effect of the depth of the final vacant space (p = 0.0018).
The post-hoc test showed that Groups I, II, and III were
significantly greater than that Group IV (p = 0.0016,
p < 0.0001, and p < 0.0001, respectively), and Group II
was significantly greater than Group I (p = 0.0354), whenthe depth of the final vacant space was set at 2.0 mm.
Group III was significantly greater than Groups II and IV
when the depth of the final vacant space was set at 4.0 mm
(p = 0.0184 and p = 0.0055, respectively). In Group II, the
gross appearance score was significantly greater when the
depth of the final vacant space was set at 2.0 mm and
3.0 mm than that of 4.0 mm (p = 0.0029 and p = 0.0074,
respectively) (Figure 5).
Regarding the histology score, the ANOVA demon-
strated a significant difference not only on the effect of
the group (p < 0.0001) but also on the effect of the depth
of the final vacant space (p = 0.0009). The post-hoc test
showed that Groups I, II, and III were significantly greater
than that Group IV (p = 0.0008, p < 0.0001, and p = 0.0004,
respectively), when the depth of the final vacant space was
set at 2.0 mm. Groups II, and III were significantly greater
than that Group IV (p = 0.0063 and p = 0.0046, respect-
ively), when the depth of the final vacant space was set at
3.0 mm, while there was no significant difference between
Groups I and IV. There were no significant differences
among the groups at 4.0 mm. In Group II, the histology
score was significantly greater when the depth of the final
vacant space was set at 2.0 mm and 3.0 mm than that at
4.0 mm (p = 0.0057 and p = 0.0100, respectively). In Group
III, the histology score was significantly greater when the
depth of the final vacant space was set at 2.0 mm and
Figure 5 Quantitative evaluations of gross appearance and histology according to the grading scale reported by Wayne et al. G-I; a 0.5-
mm gel sheet was implanted at the bottom of the defect. G-II; a 1.0-mm gel sheet was implanted at the bottom of the defect. G-III; a 5.0-mm gel
plug was implanted at the bottom of the defect. G-IV; the control group has a defect left untreated.a Significantly different from the 2.0- and 3.0-
mm depths of the final vacant space in G-II (p = 0.0029 and p = 0.0074, respectively). b Significantly different from the 2.0- and 3.0-mm depths of
the final vacant space in G-II (p = 0.0057 and p = 0.0100, respectively). c Significantly different from the 2.0- and 3.0-mm depths of the final vacant
space in G-III (p = 0.0188 and p = 0.0038, respectively). d Significantly different from the 2.0-mm depth of the final vacant space in G-I (p = 0.0206).
e Significantly different from the 2.0- and 3.0-mm depths of the final vacant space in G-II (p = 0.0032 and p = 0.0069, respectively). f Significantly
different from the 2.0- and 3.0-mm depths of the final vacant space in G-III (p = 0.0299 and p = 0.0299, respectively).
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respectively) (Figure 5).
Regarding the total score, the ANOVA demonstrated a
significant difference not only on the effect of the group
(p < 0.0001) but also on the effect of the depth of the
final vacant space (p = 0.0004). The post-hoc test showed
that Groups I, II, and III were significantly greater than
that Group IV (p = 0.0003, p < 0.0001, and p = 0.0004,
respectively), when the depth of the final vacant space
was set at 2.0 mm. Groups II and III were significantly
greater than that Group IV (p = 0.0083 and p = 0.0109,
respectively), when the depth of the final vacant space
was set at 3.0 mm, while there was no significant differ-
ence between Groups I and IV. At 4.0 mm, only Group
III was significantly greater than Group IV (p = 0.0059).
In Group I, the total score was significantly greater when
the depth of the final vacant space was set at 2.0 mm
than that at 4.0 mm (p = 0.0206). In Group II, the total
score was significantly greater when the depth of the
final vacant space was set at 2.0 mm and 3.0 mm than
that at 4.0 mm (p = 0.0032 and p = 0.0069, respectively).
In Group III, the total score was significantly greater
when the depth of the final vacant space was set at
2.0 mm and 3.0 mm than that at 4.0 mm (p = 0.0299
and p = 0.0299, respectively) (Figure 5).
Real time PCR analysis
The expression level of type-2 collagen in Groups II and III
was significantly higher than that in Group IV (p = 0.0059
and p = 0.0411, respectively) and that in Group II was
also significantly higher than that in Group I (p =
0.0473) (Figure 6).Discussion
The present study demonstrated that, when each DN
gel sheet or plug was implanted at the bottom of the
defect so that a 2- to 3-mm deep vacant space was left
in the defect, the evaluation scores were found to be the
greatest. In this implantation condition, all the evaluation
scores and the expression level of the type-2 collagen gene
in the two groups with implantation of a 1.0-mm thick
gel sheet or a 5.0-mm thick gel plug were significantly
greater than those of the untreated control group, and
there were no significant differences in those parameters
between the two groups. These results suggested that the
in vivo hyaline cartilage regeneration phenomenon induced
by DN gel is not influenced by the thickness of the gel
implanted at the bottom of a large osteochondral defect,
at least, in a range between 1.0 mm and 5.0 mm. Con-
cerning the 0.5-mm thick sheet implantation, however,
the gross observation score and expression level of type-2
collagen gene were slightly but significantly lower as
compared with the 1.0-mm thick gel sheet implantation,
while there were no significant differences in comparison
with the 5.0-mm thick gel implantation. These results
suggested that, when the thickness of the implanted gel
is too thin, below 1.0 mm, the thickness of the im-
planted DN gel slightly but significantly reduces induc-
tion ability of the in vivo hyaline cartilage regeneration
phenomenon.
We have studied the mechanism of the in vivo cartil-
age regeneration induced by the PAMPS/PDMAAm DN
gel. Our previous in vitro study [20] has shown that the
single-network PAMPS gel can differentiate chondro-
genic ATDC5 cells into chondrocytes even in an insulin-
free medium. The PAMPS network in this DN gel is
Figure 6 Gene expression of type-2 collagen, aggrecan, and Sox9 in the regenerated tissue of 2-mm depth implantation at 4 weeks.
The degree of expression of type-2 collagen mRNAs was significantly greater in the regenerated tissue in G-II and III than that in G-IV.
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similar to proteoglycans in normal cartilage. The PAMPS
network may work as an effective reservoir of signaling
molecules and growth factors like proteoglycans. This
PAMPS function may create an appropriate biological
environment for immature cells proliferating in the de-
fect space, leading to chondrogenic differentiation. An-
other possible mechanism of the induction effect by
the PAMPS/PDMAAm DN gel is related to the bio-
mechanical condition. It is also known that mechanical
microenvironment significantly affects cartilage differ-
entiation of bone-marrow derived stem cells [21,22].
Recently, Engler et al. [23] reported that elasticity of
the material on which the cultured cells are attached to
directs stem cell differentiation. For example, elastic
materials induce differentiation to the cartilage tissue,
and stiff materials induce differentiation to the bone
tissue. Therefore, the mechanical properties of the DN
gel improved by the PDMAAm gel [18,19] may enhance
the effect of the PAMPS gel on cartilage regeneration. In
addition, we have elucidated that a dynamic physical
environment is a critical factor to induce cartilage regen-
eration [24]. However, the mechanism of the in vivo cartil-
age regeneration induced by the PAMPS/PDMAAm DN
gel has not been sufficiently clarified.
The present study has added new information in order
to increase the database on the hyaline cartilage regener-
ation induced by the PAMPS/PDMAAm DN gel. In the
present study, first, the 1.0-mm and 5.0-mm thick DN
gel implants had the same ability in the in vivo hyaline
cartilage regeneration, while the ability of the 0.5-mm
thick DN gel implant was slightly but significantly infer-
ior to that of the 1.0-mm thick DN gel implant. This fact
implied that DN gel sheets thicker than 1.0 mm may
provide the same physical environment under knee mo-
tion at the bottom of the defect with the 2- to 3-mm
deep vacant space. Theoretically, however, when a very
thin gel sheet is compressed by large forces, the apparent
elastic modulus of the gel-bony floor (bone beneath the gel
sheet) complex is increased by the effect of the extremelyhigh modulus of the bony floor. Therefore, when the
thickness of a DN gel sheet was 0.5 mm in this study,
the apparent elastic modulus of the gel-bone complex
might be too high under repetitive compression loading
due to joint motion. Therefore, we speculate that the
increased apparent modulus of the gel-bone complex
under the repetitive compression loading may reduce the
cartilage regeneration.
There are some limitations in this study. First, we used a
rabbit patellofemoral joint model in this study, although
this model has been commonly used to evaluate new pro-
cedures in cartilage regeneration experiments [25-27]. The
joint which the most frequently requires a cartilage regen-
eration therapy is not the patellofemoral joint but weight-
bearing regions of the femorotibial joint in the clinical
field. Therefore, the results obtained cannot be simply
transferred to the clinical field because different results
might be obtained in the femorotibial joint model. There
is a need to conduct experimental studies with a large
animal model in order to fully evaluate the pre-clinical
efficacy. The second limitation is that we did not actu-
ally examine the mechanical properties of the DN gel
sheet or plug implanted in the bone tissue after cartilage
repair occurs. The biomechanical changes of the DN gel
may affect cartilage regeneration and durability because
the implanted DN gel, which was seen as a void space in
the histology section, was remained surrounded by bone
in the defect as it was but it is unknown whether the
DN gel properly works as subchondral bone with similar
biomechanical properties after inducing cartilage regen-
eration. The third limitation is that we performed only
short-term observations of the regenerated cartilage,
because we intended to obtain the initial evidence that
the DN gel’s thickness affected induction of the cartilage
regeneration. However, we do not know the long-term
effect of the DN gel on cartilage regeneration as well as
the biological and biomechanical changes in the DN gel
itself. To completely clarify the comprehensive effect
of the DN gel thickness on the cartilage regeneration,
long-term studies need to be conducted in the future.
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tions of the regenerated cartilage were performed. We
recognize that the biomechanical quality of cartilage is of
vital importance for cartilage tissue restoration and dur-
ability. However, we believe that the biological and histo-
logical evaluations are fundamental to evaluate cartilage
regeneration induced by synthetic gel implantation. The
fifth limitation is that we did not evaluate the cell viability
or extracellular matrix change of adjacent cartilage in the
present study. As this cartilage repair method creates a
large defect with a 2 to 3 mm depth of the vacant space
at DN gel implantation, it might cause a significant mech-
anical change in the adjacent cartilage. We observed only
minor influence on the adjacent cartilage in this animal
model based on our previous study [16]; however, long-
term studies are needed to clarify the effect of this
method.
Concerning the safety of the PAMPS/PDMAAm DN gel
as a biomaterial, we previously performed a pellet implant-
ation test into the para-vertebral muscle [28], according to
the guideline for biological evaluation of the safety of bio-
materials, which had been published by the Ministry of
Health, Labour and Welfare, Japan. Although this DN gel
implantation induced a mild cell infiltration at 1 week,
the degree of the inflammation significantly decreased
to the same degree as that of the negative control at 4
and 6 weeks. We also cultured ATDC5 cells on the
PAMPS/PDMAAm DN gel [15] as well as the single-
network PAMPS and PDMAAm gels [20]. No harmful
effects due to these gel surfaces were detected. We
believe that the PAMPS/PDMAAm DN gel is a safe bio-
material. However, we have not completed all protocols
to establish the clinical safety of this DN gel as an im-
plant. Further studies are needed to establish the clinical
safety of this gel in the near future.
As to clinical relevance, the innovative strategy with the
DN gel implantation for cartilage repair without cell cul-
ture has been proposed [15,16]. We should note that this
strategy is in sharp contrast to current prevailing strategies
that completely fill the defect with the tissue-engineered
cartilage tissue, cell-seeded scaffold material implantation,
or acellular polymer scaffolds with signaling molecules
[11-14]. In addition, we can expect this strategy to solve
the various problems and concerns in current strategies,
including donor site morbidity, two surgeries being needed,
a long non-weight bearing period, a potential risk of
zoonotic transmission, an enormous amount of money to
establish such a tissue-engineering industry system, an
extremely high medical fee for patients having the treat-
ment, and other factors [29-36]. The results of the present
study have provided important information to realize ben-
efits of this innovative strategy with the DN gel in the near
future. As described in the introduction section, a syn-
thetic implant in the bone should be as thin and small aspossible to avoid loosing the bone tissue due to the im-
plantation. However, we do not know whether this strat-
egy using a DN gel implantation is superior to other
cartilage repair procedures such as the current autologous
chondrocyte implantation technique. For the possible clin-
ical use of this treatment strategy, further studies should
be conducted to clarify these issues in the near future.
Conclusions
The 1.0-mm thick DN gel sheet had the same ability to
induce hyaline cartilage regeneration as the 5.0-mm thick
DN gel plug. However, the induction ability of the 0.5-mm
thick sheet was significantly lower when compared with the
1.0-mm thick gel sheet. The 1.0-mm DN gel sheet com-
posed of PAMPS and PDMAAm is a promising device
to establish a cell-free cartilage regeneration strategy that
minimizes bone loss from the gel implantation.
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